Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome

Gnrh Agonists

Faculty Opinions recommendation of Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726669273.793535607 ◽

2017 ◽

Author(s):

Robert Casper

Keyword(s):

High Risk ◽

Randomized Trial ◽

Early Onset ◽

Prospective Randomized Trial ◽

High Risk Women

GnRHa trigger and luteal coasting: a new approach for the ovarian hyperstimulation syndrome high-risk patient?

Reproductive BioMedicine Online ◽

10.1016/j.rbmo.2017.09.014 ◽

2018 ◽

Vol 36 (1) ◽

pp. 75-77 ◽

Cited By ~ 7

Author(s):

Barbara Lawrenz ◽

Peter Humaidan ◽

Shahar Kol ◽

Human M. Fatemi

Keyword(s):

High Risk ◽

High Risk Patient ◽

Risk Patient ◽

New Approach

Single Blastocyst Transfers in Women at High Risk for Ovarian Hyperstimulation Syndrome

Fertility and Sterility ◽

10.1016/s0015-0282(00)00983-3 ◽

2000 ◽

Vol 74 (3) ◽

pp. S96-S97

Author(s):

S.W Trout ◽

M.K Bohrer ◽

D.B Seifer

Keyword(s):

High Risk ◽

Ovarian Hyperstimulation

Implementing two strategies to avoid ovarian hyperstimulation syndrome (OHSS): use of GnRH agonists (GnRHa) to trigger final oocyte maturation associated with blastocyst cryopreservation

Fertility and Sterility ◽

10.1016/j.fertnstert.2013.07.244 ◽

2013 ◽

Vol 100 (3) ◽

pp. S517-S518

Author(s):

M.M. Carneiro ◽

A.L.M. Silva ◽

A.M.M. Cota ◽

J.P.J. Caetano

Keyword(s):

Oocyte Maturation ◽

Gnrh Agonists ◽

Final Oocyte Maturation

CLINICAL REPORT: The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome

Human Reproduction ◽

10.1093/oxfordjournals.humrep.a138185 ◽

1993 ◽

Vol 8 (7) ◽

pp. 1015-1020 ◽

Cited By ~ 110

Author(s):

R.H. Asch ◽

G. Ivery ◽

M. Goldsman ◽

J.L. Frederick ◽

S.C. Stone ◽

...

Keyword(s):

High Risk ◽

Clinical Report ◽

Severe Ovarian Hyperstimulation Syndrome

Does the Use of Highly Purified Human Menopausal Gonadotrophin (HP-HMG) avoid Ovarian Hyperstimulation Syndrome (OHSS) in Polycystic Ovary (PCO) Patients in Assisted Reproduction (IVF/ICSI)?

Gynecology & Obstetrics ◽

10.4172/2161-0932.1000273 ◽

2015 ◽

Vol 05 (02) ◽

Cited By ~ 1

Author(s):

Elmahaishi Asma Mohammed Said

Keyword(s):

Assisted Reproduction ◽

Polycystic Ovary ◽

Human Menopausal Gonadotrophin

Effect of bromocriptine on the severity of ovarian hyperstimulation syndrome and outcome in high responders undergoing assisted reproduction

Journal of Human Reproductive Sciences ◽

10.4103/0974-1208.69342 ◽

2010 ◽

Vol 3 (2) ◽

pp. 85 ◽

Cited By ~ 12

Author(s):

Vinita Sherwal ◽

Sonia Malik ◽

Vandana Bhatia

Keyword(s):

Assisted Reproduction ◽

High Responders

Rare genetic variants suggest dysregulation of signaling pathways in low- and high-risk patients developing severe ovarian hyperstimulation syndrome

Journal of Assisted Reproduction and Genetics ◽

10.1007/s10815-020-01941-0 ◽

2020 ◽

Vol 37 (11) ◽

pp. 2883-2892

Author(s):

L. Borgwardt ◽

K. W. Olsen ◽

M. Rossing ◽

R. Borup Helweg-Larsen ◽

M. Toftager ◽

...

Keyword(s):

High Risk ◽

Signaling Pathways ◽

Genetic Variants ◽

Severe Ovarian Hyperstimulation Syndrome

High Risk Patients ◽

Risk Patients ◽

Rare Genetic Variants ◽

Withholding luteal hcg is associated with decreased live birth (LB) in women at high risk for ovarian hyperstimulation syndrome (OHSS) despite "intensive" luteal support with intramuscular progesterone (IMP)

Fertility and Sterility ◽

10.1016/j.fertnstert.2019.07.676 ◽

2019 ◽

Vol 112 (3) ◽

pp. e215-e216

Author(s):

Lauren A. Bishop ◽

Natalie Clark Stentz ◽

Micah J. Hill ◽

Kate Devine ◽

Saioa Torrealday ◽

...

Keyword(s):

High Risk ◽

Live Birth ◽

Luteal Support

GnRH antagonist administration for patients at high risk of severe Ovarian Hyperstimulation Syndrome (OHSS) down regulated GnRH agonist

http://isrctn.org/> ◽

10.1186/isrctn58806684 ◽

2012 ◽

Author(s):

Mohamed Aboulghar

Keyword(s):

High Risk ◽

Gnrh Agonist ◽

Gnrh Antagonist ◽

Severe Ovarian Hyperstimulation Syndrome